Notably, the combined analysis of CSF α-synuclein, AD-related biomarkers, and NfL demonstrates high to very high diagnostic accuracy in differentiating PSP and CBS from PD, AD, MSA, and FTD [117,118]. This evidence concerns the gene NEFL and Parkinson disease.